HomeOpen Access NewsPharmaceutical Industry

Pharmaceutical Industry

NPA analysis finds over 6 million hours spent in A&E on cases treatable by community pharmacies

A new report by the National Pharmacy Association reveals that patients spent over 6 million hours in A&E last year for minor health issues that could have been managed by community pharmacies, highlighting an opportunity to ease pressure on emergency services.

Google searches for vaccine infertility increased by 34,900% following misinformation incident

Google searches for infertility relating to COVID-19 vaccines increased by 34,900% after a pair of physicians submitted a petition questioning their safety.

How games can be used to combat health and vaccine misinformation

Soraiya Verjee, Business Development Director of Sea Monster, discusses how the use of games and animation can combat COVID-19 and vaccine misinformation.

Ensuring regulatory compliance for Medical Cannabis

Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.

9 in 10 adults have COVID-19 antibodies, according to new survey

A new Government survey has found that 9 in 10 adults have COVID-19 antibodies, but experts say more data is needed before 'Freedom Day'.

CBD oil for pain: What the research shows

Oils by Simpson of 2012 supplies organic full-spectrum CBD cannabis oil products. CBD oil is popular and commonly used for its potent therapeutic benefits, but what about its effect on pain? Here’s what the research shows.

MHRA approves Pfizer vaccine for 12-15-year-olds

The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the Pfizer/BioNTech COVID-19 vaccine is safe to use in 12-15-year-olds.

Canvassing public awareness on veterinary medicines

Roxane Feller, Secretary General of AnimalhealthEurope, explains to us canvassing public awareness on the benefits of veterinary medicines.

Commission signs third contract for 1.8 billion BioNTech-Pfizer doses

The European Commission has announced that it has signed a third contract to secure an additional 1.8 billion BioNTech-Pfizer vaccine doses.

Logistics & supply chain will win the COVID-19 war

Professor Richard Wilding argues that biochemistry is winning the battle against coronavirus, but logistics and supply chain will win the war.

EU4Health: Building healthcare systems of tomorrow

European Commission Director General for Health and Food Safety Sandra Gallina details the ambitious EU4Health Programme proposed as a response to COVID-19.

Will 2021 see the UK’s cannabis industry bloom?

John Binns & David Hardstaff from BCL Solicitors LLP, reveal if 2021 will be the year that sees the UK’s cannabis industry bloom.

Benchmarking Regulatory systems governing veterinary medicines – part 2

Rick Clayton, Technical Director, AnimalhealthEurope, in the second chapter of this three-part series, continues to examine Benchmarking Regulatory systems governing veterinary medicines.

Building readiness for innovative health technologies

Senior Researcher in Social Science Michael Morrison explains why disruptive technologies need institutional and systemic readiness to truly realise the benefits of healthcare innovation.

Why COVID vaccine development was exceptionally speedy

Ram May-Ron, Managing Partner at FreeMind Group, explains why COVID vaccine development was exceptionally speedy.

COVID-19 vaccine does not damage placentas

Researchers from Northwestern Medicine have studied the placentas from patients who received the COVID-19 vaccine during pregnancy and found no evidence of damage.

Immune system research: Vaccines and immunotherapeutics

Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders